Navigation Links
New Analysis Confirms Albumin Preserves Kidney Function and Improves Survival in Common Abdominal Infection of Liver Disease
Date:1/21/2013

KING OF PRUSSIA, Pa., Jan. 21, 2013 /PRNewswire/ -- Treatment with albumin reduces renal impairment and mortality in cirrhotic patients with spontaneous bacterial peritonitis (SBP), one of the most common bacterial infections in this patient population, according to a new meta-analysis supported by CSL Behring and published today in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association Institute. Albumin, a natural plasma-derived protein that expands blood plasma volume, is widely used in conjunction with large-volume paracentesis to treat tense ascites, with vasoconstrictors for type 1 hepatorenal syndrome and with antibiotics for SBP.

"While current clinical guidelines indicate the benefits of albumin for patients with SBP, questions regarding patient selection and albumin dosing in the management of the condition still linger," said Francesco Salerno , M.D., Professor of Internal Medicine at the University of Milan in Italy, and lead author of the meta-analysis. "Based on our quantitative findings and the clear benefits demonstrated, it seems prudent to treat all SBP patients with albumin, regardless of whether they are high-risk or low-risk for poor outcome."

SBP occurs without any obvious source of intra-abdominal infection. Several factors are believed to contribute to SBP including bacterial overgrowth in the intestine, passage of the bacteria across an impaired intestinal barrier into the blood stream and abdominal cavity, and a deficient local immune response to the invasion. Renal impairment, a frequent complication of SBP, is associated with high risk of mortality, which may reach 30% despite prompt treatment.

The meta-analysis, which included results from four randomized controlled trials with 288
'/>"/>

SOURCE CSL Behring
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. XBiotech Reports Positive Phase II Interim Analysis Results in Vascular Disease
2. Valeritas Announces The Publication Of A Retrospective Analysis Of Patient-Reported Data On The V-Go In The Current Issue Of Endocrine Practice
3. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
4. Analysis Finds Improvements in Health-Related Quality of Life for Hereditary Angioedema Patients Treated with C1-Inhibitor
5. Convenient New iHealth Blood Pressure Monitors and Body Analysis Scale Now Available for Purchase at Major Retailers and Online
6. Leavitt Partners Health Reform Bracketology analysis considers impact of U.S. elections on the Affordable Care Act
7. XBiotech Reports Positive Phase II Interim Analysis Results From Type 2 Diabetes Study
8. Generics Analysis: Key Patent Case Reviews
9. Reliance Pharmaceuticals: Biosimilars Company Analysis
10. US Cancer Vaccine Market Analysis
11. New Analysis Shows Illicit Drug Use May Vary by Payer Type: Detection Rates as High as 17 Percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 ... My Diabetes Emergency Plan at the 2015 @NatHurricaneCon ... to be prepared to manage your #diabetes before emergencies ... (ACE) – the charitable, educational and scientific arm of ... joined forces with Lilly Diabetes to share the ...
(Date:3/30/2015)... 2015  The investigational S- equol nutritional supplement ... symptoms, such as hot flashes, according to a new ... Health .[i] "Current data suggest that women ... vasomotor symptoms and possibly additional benefits, such as skin ... equol, physicians and health care professionals may consider the ...
(Date:3/30/2015)... WHITE PLAINS, N.Y. , March 30, 2015 /PRNewswire-USNewswire/ ... developing new treatments for patients with a rare and ... from a recent licensing agreement with a new biotechnology ... has been funding this work, led by Assistant Professor ... Tomasz Cierpicki , Ph.D., at the University of Michigan, ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 2New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 3New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 6Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3
... -- ImClone,Systems Incorporated and Bristol-Myers Squibb Company ... ERBITUX(R) (Cetuximab) plus,gemcitabine (a chemotherapy) in patients ... did not meet its,primary endpoint of improving ... Oncology Group (SWOG), a cancer,center network sponsored ...
... ALTO, Calif., April 09, 2007 /PRNewswire-FirstCall/ --,Telik, ... its,multicenter Phase 2 trial of the triplet ... paclitaxel will be,presented at the 98th annual ... (AACR) in Los Angeles. Preclinical studies of,cellular ...
Cached Medicine Technology:Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 2Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 3Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 4Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 5Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 6Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 7Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 8Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 9Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3
(Date:3/31/2015)... March 31, 2015 The report ... (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, ... Hospital)–Forecast to 2019” analyzes and studies the major ... America, Europe, Asia-Pacific and the Rest of the ... market is expected to reach $3.58 billion by ...
(Date:3/31/2015)... California (PRWEB) March 31, 2015 ... company that specializes in providing online solutions ... announced today it has achieved full accreditation ... Healthcare Network Accreditation Program (HNAP) from the ... , EHNAC’s HNAP accreditation runs in two-year ...
(Date:3/31/2015)... Diane Blackburn-Zambetti is the Director of ... Research Foundation (Meso Foundation). Blackburn-Zambetti will present an ... the BoRit Asbestos Superfund Citizen Advisory Group Meeting ... discuss anatomy, six types of asbestos, asbestos products, ... prevention and proper communication with your healthcare provider. ...
(Date:3/31/2015)... 2015 Dr. Stewart Shofner of ... sunshine; however, it's important to be aware of hazards related ... say more than 90 percent of eye injuries can ... safety glasses. Dr. Shofner shares five popular activities and important ... Yard Work. While using a lawn mower, leaf-blower, weed trimmer, ...
(Date:3/31/2015)... 2015 In a normal year for ... are anxiously awaited. After a winter of waiting, cabin ... winter snowpack in the mountain high country melts back ... the high trails. The winter of 2014-2015, according to ... very different. For the first time ever many high ...
Breaking Medicine News(10 mins):Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 2Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 3Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 4Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 2Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 3Health News:Mesothelioma Foundation to speak at BoRit Asbestos Superfund Citizen Advisory Group Meeting 2Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 2Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 3Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 4Health News:2014-15 winter drought offers unique opportunity for Oregon and California hikers and backpackers reports fresh water advocate 2Health News:2014-15 winter drought offers unique opportunity for Oregon and California hikers and backpackers reports fresh water advocate 3
... 7 Natural Alternatives International, Inc. ("NAI") (Nasdaq: ... and marketer of customized nutritional supplements, today announced ... Randell Weaver,s employment with NAI ended.NAI also announced ... with Wells Fargo Bank. Among other changes ...
... Legislation Aimed at Protecting Medicare Beneficiaries Introduced on ... 7 Physical therapy ... limited by arbitrary financial caps under legislation introduced ... according to the American Physical Therapy Association (APTA). ...
... Acute lymphoblastic leukemia is most common pediatric cancer , , ... leukemia cells predicts which children with acute lymphoblastic leukemia ... online Jan. 7 in the New England Journal ... physicians fine-tune treatment for different subsets of patients. , ...
... SB 203, known as Emily,s Law, has received ... in the state of Ohio. Named after Emily Jerry, ... pharmacy technicians. The law, which was originally sponsored by ... National Pharmacy Technician Association. Emily,s Story , Emily ...
... used to treat heart failure, slowed cell growth, study ... a drug used for many years to treat irregular ... cancer-fighting agent, researchers report. , Cancer cells need to ... these cells are oxygen-deprived and need to switch on ...
... A medical revolution emerges when,technology blends with smart ... new Smart OR(TM) - a specialized neurosurgical suite ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20081016/CLTH057 ... configuration of advanced imagery and mapping technology, the ...
Cached Medicine News:Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 3Health News:Gene Governs Response to Leukemia Chemotherapy 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3Health News:Heart Drug May Be a Cancer Fighter 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: